Bayer Posts Impressive But Unsustainable Sales Growth

BMI View: German drugmaker Bayer is unlikely to repeat its so-far impressive performance in Asia Pacific in the remainder of 2011, primarily due to the region's stagnating attractiveness to multinational drugmakers, as evident in BMI's Business Environment Ratings for Q411.

To read the full article, please choose one of the following options: